Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV002813642 | SCV003606425 | uncertain significance | Inborn genetic diseases | 2022-02-11 | criteria provided, single submitter | clinical testing | The c.76G>A (p.E26K) alteration is located in exon 2 (coding exon 2) of the SLC30A2 gene. This alteration results from a G to A substitution at nucleotide position 76, causing the glutamic acid (E) at amino acid position 26 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |